ZCZhiguang Chen

Zhiguang Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhiguang Chen has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Donglin Bian

    Department of Ultrasound, The First Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, China

    1 shared publication
  • Genyuan Zhang

    Department of Ultrasound, the First Hospital of China Medical University. China Medical University, No.155, Nanjing North Road, Shenyang 110001, China

    1 shared publication
  • Hongzan Sun

    Department of Nuclear Medicine, Shengjing Hospital of China Medical University, Shenyang, China

    1 shared publication
  • Jin Sun

    Shenyang Pharmaceutical University

    1 shared publication
  • Liang Sang

    Department of Ultrasound, The First Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, China

    1 shared publication
  • Liang Sang

    Department of Ultrasound, the First Hospital of China Medical University. China Medical University, No.155, Nanjing North Road, Shenyang 110001, China

    1 shared publication

Latest Publications

  • Open Access

    Sensitization strategy for sonodynamic therapy

    by Sinong Li, Ziyi Yang, Ying Zhang, Genyuan Zhang, Zoujuan Cai, Yihan Xie, Zhiqun Bai, Jin Sun, Hongzan Sun, Zhiguang Chen, et al.

    Sonodynamic therapy (SDT), a tumor treatment modality characterized by deep tissue penetration and high spatiotemporal precision, faces multiple challenges in clinical translation, including suboptimal sonosensitizer efficiency, suppression by the tumor microenvironment (TME), and insufficient induction of antitumor immune responses. This paper systematically reviews the multifaceted sensitization strategies of SDT, breaking away from traditional single-optimization approaches to establish a comprehensive synergistic enhancement framework spanning the entire chain involving “material design-microenvironment regulation-immune remodeling-synergistic therapy.” In sonosensitizer engineering, current research emphasizes advanced design strategies—including defect engineering, heterostructure construction, and piezoelectric materials—to markedly enhance reactive oxygen species (ROS) generation through band structure modulation and mechano-electro-chemical coupling effects. To overcome the TME-associated constraints, a series of innovative strategies such as hypoxia alleviation, antioxidant depletion, metabolic reprogramming and bacteria-mediated targeted delivery have been developed to mitigate ROS scavenging and improve tumor selectivity. Furthermore, this review summarizes how SDT is integrated with multiple synergistic modalities such as chemodynamic therapy, phototherapy, immunotherapy, and ferroptosis/cuproptosis induction and systematically elucidates the underlying mechanisms and therapeutic potential of these combinations in triggering immunogenic cell death, reversing tumor immunosuppression, and ultimately enabling diagnostic-therapeutic integration. Despite persistent challenges in nanodelivery, controllable ROS generation, and clinical standardization, this review highlights that the development of multimodal, responsive, and biohybrid platforms is driving SDT toward a new paradigm of precise and intelligent cancer treatment. Collectively, these findings provide a systematic strategic blueprint with translational potential for treating deep-seated and drug-resistant solid tumors.


  • Top Cited Papers
    Open Access

    Piezoelectric Heterojunction-driven Biomedical Revolution: From Construction Principles to Diagnostic and Therapeutic Applications

    by Zhiguang Chen, Wei Zhang, Xiujuan Qu, Yunfei Zhang

    Piezoelectric heterojunctions are emerging as a transformative class of smart biomaterials, revolutionizing biomedical applications through their unique mechano-electrical coupling effects. A central challenge hindering their full potential lies in the systematic understanding and utilization of their complex interfacial enhancement mechanisms. This review aims to establish a comprehensive framework that bridges fundamental principles to clinical translation. We begin with an in-depth analysis of the core enhancement mechanisms in piezoelectric heterojunctions, focusing on the synergistic interplay between the built-in electric field and band engineering that promotes efficient charge separation. We then provide a critical discussion of the ongoing debate surrounding their catalytic mechanism, reconciling the distinctions and connections between band theory and the surface screening charge model. Furthermore, we construct a multidimensional classification system centered on material dimensionality and composition to offer systematic guidance for the rational design and performance optimization of piezoelectric heterojunctions. In terms of applications, this review offers a comprehensive survey of the cutting-edge progress of piezoelectric heterojunctions in efficient cancer therapy, tissue regeneration, antibacterial strategies, and self-powered biosensing. We emphasize that the superiority of these heterojunctions stems from their ability to overcome the bottlenecks of low efficiency and mono-functionality inherent in single-component piezoelectric materials through sophisticated interface design, while also maximizing therapeutic outcomes via multimodal synergistic strategies. Finally, we critically analyze the formidable challenges this field faces concerning biosafety, scalable fabrication, and clinical translation, and offer perspectives on its future development toward intelligent theranostic systems. This review is intended to provide solid theoretical guidance and forward-looking insights for the design of next-generation, high-performance piezoelectric biomaterials.


  • Open Access

    Piezo-catalytic immunotherapy: mechanisms and feasibility in cancer treatment

    by Zhiguang Chen, Liang Sang, Donglin Bian, Yanjun Liu, Zhiqun Bai

    Over the past decade, immunotherapy has revolutionized the clinical management of numerous cancer types. However, only a subset of patients derives long-term durable tumor control from it. Intriguingly, several emerging therapeutic strategies harnessing reactive oxygen species (ROS)-mediated immunogenic cell death (ICD) hold promise for enabling precision immunotherapy in cancer, with sonodynamic therapy emerging as a notable example. The utilization of piezoelectric materials as sonosensitizers can effectively enhance ROS production, thereby augmenting the efficacy of ICD-induced immunotherapy. Additionally, electrical stimulation generated by the piezoelectric effect can further induce immune response activation and necroptosis, achieving a synergistic effect in piezo-catalytic immunotherapy. Herein, we will systematically review the pathways and potential mechanisms underlying piezo-catalytic immunotherapy, offering novel insights for the exploration of cancer immunotherapy strategies.